ArticleBMJ public health2025
Global mortality burden of lung cancer and mesothelioma attributable to occupational asbestos exposure and the impact of national asbestos ban policies: a population-based study, 1990-2021.
Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Occupational asbestos exposure and lung cancer: contemporary research trends, exploratory genetic evidence, and global burden from 1990 to 2021.Journal of thoracic disease · 2026Article
- VISTA drives tumour-intrinsic proliferation in mesothelioma cells.British journal of cancer · 2026Article
- Persistence of Asbestos-Containing Friction Materials in the Hungarian Waste Stream Twenty Years After the European Union Ban.International journal of environmental research and public health · 2026Article
- Health, Work, Invisibilities and Collective Resistance in an Asbestos-Exposed Territory in the Pedro Leopoldo Region, (MG), Brazil.International journal of environmental research and public health · 2026Article
- Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2026Review
- Surveillance of Non-Malignant Asbestos-Related Diseases in an Exposed Population: A Scoping Review.Annals of global health · 2026Article
- Epithelioid Mesothelioma Cells Exhibit Increased Ferroptosis Sensitivity Compared to Non-Epithelioid Mesothelioma Cells.Cancers · 2025Article
- Projecting future mortality risk of pleural mesothelioma in Italy (2020-2034): Bayesian age-period-cohort analysis over 40 years of death registration.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Asbestos-related thoracic cancers (ARTCs), including asbestos-related lung cancer and mesothelioma, constitute the majority of deaths due to asbestos exposure. This study evaluates the global mortality burden of ARTCs and the influence of national asbestos ban policies. Methods: We used data from the Global Burden of Diseases Study 2021 to estimate the mortality burden of ARTCs and analyse trends from 1990 to 2021, stratified by sex, location and sociodemographic index (SDI) quintile. Decomposition analysis identified contributors to changes in the ARTC burden, and future projections were made using the Bayesian age-period-cohort model. The relationship among asbestos ban policies, SDI and ARTC deaths was also examined. Results: In 2021, an estimated 216 535 deaths from ARTCs (including 29 619 from mesothelioma and 189 398 from lung cancer) resulted in an age-standardised mortality rate (ASMR) of 4.1 per 100 000 population, accounting for over 95% of deaths from asbestos-related cancers. Notable variation in ARTC deaths was observed across age, sex, location and SDI quintile, with higher ASMR among men, older adults and countries with higher SDI. From 1990 to 2021, there was a global decline in ASMR from ARTCs, particularly among men and in cases of asbestos-related lung cancer, although increases were noted in low to middle SDI quintiles. Despite a consistent reduction in ASMR, the absolute number of ARTC deaths is rising due to population growth and ageing. Countries with implemented asbestos bans have historically and currently faced higher ARTC burdens. A positive impact of asbestos ban policies on reducing ASMR from ARTCs was observed, although the effects take decades to manifest. Conclusions: Substantial geographic and sociodemographic disparities exist in the burden and trends of ARTCs. Countries with asbestos bans have historically faced higher ARTC burdens, and while these bans significantly reduce ASMR from ARTCs, the benefits take decades to become evident.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.